Dongwha Pharm.Co.,Ltd (KRX:000020)
South Korea · Delayed Price · Currency is KRW 6,250.00
-10.00 (-0.16%)
At close: Nov 5, 2025
Dongwha Pharm.Co.,Ltd Company Description
Dongwha Pharm.Co.,Ltd manufactures and sells pharmaceutical products in South Korea.
It offers ethical products in the areas of alimentary system, antibiotic, cardiovascular/metabolic disease, NSAID/respiratory system, muscle relaxants/musculoskeletal system, nervous system, and dermatological/urinary system; OTC products in the areas of alimentary system, cold remedy, NSAID/respiratory system, dermatological, mouth and tooth, hepatic protectors, nutrients, tonics, topic analgesic, antihistamines, sore throat, and others; quasi drugs; health subsidiary foods; foods and drinks; and cosmetics.
The company also exports its products. Dongwha Pharm.Co.,Ltd was founded in 1897 and is headquartered in Seoul, South Korea.
Dongwha Pharm.Co.,Ltd
| Country | South Korea |
| Founded | 1897 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 812 |
Contact Details
Address: FastFive Tower Seoul, 04522 South Korea | |
| Phone | 82 2 2021 9300 |
| Website | dong-wha.co.kr |
Stock Details
| Ticker Symbol | 000020 |
| Exchange | Korea Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7000020008 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Chang-Soo Cho | Co-Chief Executive Officer and President |
| Doh Joon Yoon | Chairman of the Board and Co-Chief Executive Officer |